Anne Nunes
Chief Operating Officer en ANIKA THERAPEUTICS, INC. .
Fortuna: 281 584 $ al 31/03/2024
Perfil
Anne Nunes is currently the Chief Operating Officer & Senior Vice President at Anika Therapeutics, Inc. She previously worked as the Head of Research & Development at Eli Lilly & Co. and as the Senior Vice President of Global Operations at Smith & Nephew plc.
Ms. Nunes holds an MBA from Questrom School of Business and an undergraduate degree from the University of Illinois At Urbana–Champaign.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
ANIKA THERAPEUTICS, INC.
0.08% | 15/03/2024 | 11 086 ( 0.08% ) | 281 584 $ | 31/03/2024 |
Cargos activos de Anne Nunes
Empresas | Cargo | Inicio |
---|---|---|
ANIKA THERAPEUTICS, INC. | Chief Operating Officer | 01/09/2021 |
Antiguos cargos conocidos de Anne Nunes.
Empresas | Cargo | Fin |
---|---|---|
SMITH & NEPHEW PLC | Corporate Officer/Principal | 01/01/2021 |
ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | - |
Formación de Anne Nunes.
Questrom School of Business | Masters Business Admin |
University of Illinois At Urbana–Champaign | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
ANIKA THERAPEUTICS, INC. | Health Technology |
SMITH & NEPHEW PLC | Health Technology |
- Bolsa de valores
- Insiders
- Anne Nunes